Immunis Pharma India Private Limited
Founded in 2021 and headquartered in Haryana, India.
2021 | Mahendragarh, Haryana (India) | Active
Immunis Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 10 Months
About Immunis Pharma India
Immunis Pharma India Private Limited (IPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 2021 (Three years and ten months 18 days old ). Its registered office is in Mahendragarh, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sharmila Devi and Sumit Kumar serve as directors at the Company.
Company Details
- Location
Mahendragarh, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230HR2021PTC096578
- Company No.
096578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Chemicals
Pharmaceuticals
Immunis Pharma India Private Limited
Explore comprehensive data for Immunis Pharma India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Immunis Pharma India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharmila Devi  | Director | 26-Jul-2021 | Current |
| Sumit Kumar | Director | 26-Jul-2021 | Current |
Financial Performance of Immunis Pharma India.
Enhance accessibility to Immunis Pharma India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Immunis Pharma India?
Unlock access to Immunis Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Agrihitkari Farmer Producer Company Limited
Sharmila Devi and Sumit Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Immunis Pharma India?
Immunis Pharma India has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immunis Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immunis Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Immunis Pharma India
Recent activity within the organization
- Director Appointment
Sharmila Devi was appointed as a Director was appointed as a Director on 26 Jul 2021 & has been associated with this company since 3 years 10 months .
- Director Appointment
Sumit Kumar was appointed as a Director was appointed as a Director on 26 Jul 2021 & has been associated with this company since 3 years 10 months .
- Company Incorporation
Immunis Pharma India Private Limited was registered on 26 Jul 2021 with Roc Delhi & aged 3 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Immunis Pharma India Private Limited?
Immunis Pharma India Private Limited was incorporated on 26 Jul 2021.
What is authorized share capital and paid-up capital of Immunis Pharma India Private Limited?
The authorized share capital of Immunis Pharma India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Immunis Pharma India Private Limited?
Currently 2 directors are associated with Immunis Pharma India Private Limited.
- Sharmila Devi
- Sumit Kumar
What is the registered address of Immunis Pharma India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Immunis Pharma India Private Limited is H.No. 498 Adarsh Colony, Ward No. 15 India, Mahendragarh, Haryana, 123029.
What is the corporate identification number (CIN) and company number of Immunis Pharma India Private Limited?
The corporate identification number (CIN) of Immunis Pharma India Private Limited is U24230HR2021PTC096578 and the company number is 096578 as per Ministry of Corporate Affairs (MCA).
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records